Philip Morris: Marlboro owner sells UK inhaler firm over backlash

Published On Sep 17, 2024, 9:33 PM

Philip Morris International (PMI), the company behind Marlboro cigarettes, has sold its inhaler company, Vectura Group, for £150 million ($198 million) after purchasing it for over £1 billion three years ago. The sale is part of PMI's strategy to shift towards smoke-free products like vaping, amidst criticism of hypocrisy due to its ongoing cigarette sales. PMI's management has indicated a continued interest in the inhaler sector, despite health charities' skepticism about the company's commitment to reducing cigarette sales, which still constituted over 60% of their recent revenues.

Stock Forecasts

Despite the sale being framed as part of a strategic shift, the significant loss from Vectura could reflect negatively on PMI's financial health and investor confidence. The ongoing reliance on cigarette sales raises concerns about the long-term growth potential of the company as it transitions to smoke-free products. As a result, investors may view this transition with caution.

Related News

Philip Morris International bought Vectura Group just three years ago in a deal worth more than £1bn.